Katherine Dawson, MD
Biogen
Dr. Katherine Dawson, MD is Senior Vice President, Therapeutics Development Unit, leading development efforts for Biogen’s emerging disease focus areas. She has over 20 years of experience developing therapies for neurologic disorders at Biogen and has served on the Research and Development Leadership team and the Medical Leadership team in multiple roles. Dr. Dawson has also served on the Biogen Foundation Board since 2016 and is a member of the National Academy of Sciences, Engineering and Medicine’s Forum on Drug Discovery, Development and Translation. She is a neurologist who completed residency and fellowship at Massachusetts General Hospital and was an Attending Physician in the Neuromuscular Diagnostic Center.